Evidence map›Paper›PMID 38275382›Full record

ReviewBiomedicines2023

The Therapeutic Potential of Pericytes in Bone Tissue Regeneration.

Assel Issabekova, Gulshakhar Kudaibergen, Aliya Sekenova, Aidar Dairov, Madina Sarsenova, Sholpan Mukhlis, Abay Temirzhan, Murat Baidarbekov, Saule Eskendirova, Vyacheslav Ogay

Open access · goldAbstract readReview
In one paragraph

Review in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Assel IssabekovaStem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan.
Gulshakhar KudaibergenStem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan.ORCID 0000-0002-0779-4099
Aliya SekenovaStem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan.
Aidar DairovStem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan.
Madina SarsenovaStem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan.
Sholpan MukhlisStem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan.
Abay TemirzhanNational Scientific Center of Traumatology and Orthopedics Named after Academician N.D. Batpenov, Astana 010000, Kazakhstan.
Murat BaidarbekovNational Scientific Center of Traumatology and Orthopedics Named after Academician N.D. Batpenov, Astana 010000, Kazakhstan.
Saule EskendirovaStem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan.
Vyacheslav OgayStem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan.ORCID 0000-0001-5029-5255
National Center for Biotechnology · KZ

Funding

Ministry of Education and Science of the Republic of Kazakhstan No. AP09259357
6 · The paper itself

Abstract

Pericytes, as perivascular cells, are present in all vascularized organs and tissues, and they actively interact with endothelial cells in capillaries and microvessels. Their involvement includes functions like blood pressure regulation, tissue regeneration, and scarring. Studies have confirmed that pericytes play a crucial role in bone tissue regeneration through direct osteodifferentiation processes, paracrine actions, and vascularization. Recent preclinical and clinical experiments have shown that combining perivascular cells with osteogenic factors and tissue-engineered scaffolds can be therapeutically effective in restoring bone defects. This approach holds promise for addressing bone-related medical conditions. In this review, we have emphasized the characteristics of pericytes and their involvement in angiogenesis and osteogenesis. Furthermore, we have explored recent advancements in the use of pericytes in preclinical and clinical investigations, indicating their potential as a therapeutic resource in clinical applications.

Indexed as

bone defectosteogenesispericyteregeneration

Identifiers

PMID38275382
PMCPMC10813325
OpenAlexW4390032855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.